Skip to main content
OpenTrials
Completed

NCT Number: NCT00684684

Safety and Feasibility Study of the Chartis System

The purpose of this study is to evaluate the safety and feasibility of the Chartis System in measuring air flow and pressures in isolated lung compartments during bronchoscopy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Thoraxklinik am Universitatsklinikum Heidelberg

Heidelberg, D-69126, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Scheduled to undergo clinically indicated routine diagnostic bronchoscopy

Exclusion criteria

  • Hyperexcretive chronic bronchitis or excessive sputum secretion
  • Active pulmonary infection
  • FEV1 <20% predicted
  • FVC <50% predicted

Treatment and study plan

Chartis System

Device

Assessment of airway flow and pressure

Primary outcomes

  1. Adverse events

    Time frame: Until discharge or 24 hours post procedure

Secondary outcomes

  1. Technical success

    Time frame: During procedure

Sponsors and collaborators

Lead sponsor

Pulmonx Corporation

Industry

Registry information

Official study title

A Safety and Feasibility Study of the Chartis System During Diagnostic Bronchoscopy

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
May 28, 2008
Registry last updated
Jan 22, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.